Barton Crockett

Allen Klee

Derek Greenberg

- Emerald Holding Inc. (EEX) reported **Q3 2025 revenue of $77.5 million** and **adjusted EBITDA of $12.8 million**. Year-to-date, total revenue reached **$330.7 million** and adjusted EBITDA was **$90.8 million**.  **[0001579214_2221095_4]** 
- The company updated its full-year 2025 guidance, raising and narrowing the range to **$460 million to $465 million for revenue** and **$122.5 million to $127.5 million for adjusted EBITDA**, reflecting the Generis acquisition and increased visibility.  **[0001579214_2221095_1]** **[0001579214_2221095_5]** 
- **Q3 organic revenue declined 6.8%** year over year, primarily due to construction at the Las Vegas Convention Center and tariff headwinds, which had an approximately **6% negative impact** on organic revenue for a large event.  **[0001579214_2221095_4]** **[0001579214_2221095_6]** 
- Emerald completed the acquisition of Generis in Q3 2025, which is expected to contribute an additional **$10 million in revenue in 2026** that was not recognized in 2025 due to timing.  **[0001579214_2221095_1]** **[0001579214_2221095_4]** **[0001579214_2221095_7]** 
- The Board approved an extension and expansion of the share repurchase authorization for up to **$25 million** through December 31, 2026, with **$20.3 million** remaining under the prior authorization at the end of Q3. A quarterly dividend of **$0.015 per share** was also declared.  **[0001579214_2221095_5]**

Emerald Holding Inc. Reports Q3 2025 Results, Updates Full-Year Guidance, and Details Acquisitions

- Emerald Holding reported **revenues of $77.5 million** for **Q3 2025**, an increase of **6.7%** over the prior year, with a **net loss of $14.4 million**.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_1]**  **Adjusted EBITDA for Q3 2025 was $12.8 million**, a **2.4%** increase.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_1]**  For the **nine months ended September 30, 2025**, revenues increased **13.3% to $330.7 million**, and Adjusted EBITDA rose **32.4% to $90.8 million**.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_0]** 
- The company **updated its Full Year 2025 guidance**, raising the revenue range to **$460–$465 million** and Adjusted EBITDA to **$122.5–$127.5 million**, primarily due to the Generis acquisition.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_0]** 
- Emerald's Board of Directors **extended and expanded its share repurchase program** to allow for up to **$25.0 million** in repurchases through December 31, 2026.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_1]**  The company repurchased **116,094 shares for $0.5 million in Q3 2025** and **3.8 million shares for $16.2 million year-to-date 2025**.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_1]**  A dividend of **$0.015 per share** was declared for Q4 2025.  **[1579214_4c76688ea5c0422aae5381f9e85fea7a_1]**

Emerald Holding Reports Q3 2025 Financial Results and Updates Full-Year Outlook

- Emerald reported **Q3 2025 revenue of $77.5 million** and **Adjusted EBITDA (ex-insurance) of $12.8 million**, resulting in a **diluted loss per share of $(0.07)**.  **[0001579214_2220377:12]**  Year-to-date 2025, the company achieved **13.3% year-over-year revenue growth** and **32.4% year-over-year Adjusted EBITDA growth**.  **[0001579214_2220377:5]** 
- The company updated its **Full Year 2025 guidance**, raising the revenue range to **$460-$465 million** and Adjusted EBITDA to **$122.5-$127.5 million**, primarily reflecting the acquisition of Generis.  **[0001579214_2220377:5]** **[0001579214_2220377:14]** 
- Emerald repurchased **116,094 shares** for **$0.5 million** in Q3 2025 and announced an extension and expansion of its share repurchase program, allowing for **$25.0 million** in repurchases through December 31, 2026.  **[0001579214_2220377:5]** **[0001579214_2220377:12]**  A dividend of **$0.015 per share** was also declared for the quarter ending December 31, 2025.  **[0001579214_2220377:5]** **[0001579214_2220377:12]**

Emerald announces Q3 2025 results and updates full-year guidance

- Emerald Holding, Inc. reported **Q3 2025 revenues of $77.5 million**, an increase of **6.7%** over the prior year period, and **year-to-date 2025 revenues of $330.7 million**, up **13.3%**.  **[1579214_0001193125-25-259357_eex-ex99_1.htm:0]** **[1579214_0001193125-25-259357_eex-ex99_1.htm:2]** 
- **Adjusted EBITDA for Q3 2025 was $12.8 million**, a **2.4%** increase, and **year-to-date Adjusted EBITDA was $90.8 million**, a **32.4%** increase.  **[1579214_0001193125-25-259357_eex-ex99_1.htm:0]** **[1579214_0001193125-25-259357_eex-ex99_1.htm:2]**  The company reported a **net loss of $14.4 million** for Q3 2025 and a **net loss of $0.5 million** year-to-date 2025.  **[1579214_0001193125-25-259357_eex-ex99_1.htm:0]** **[1579214_0001193125-25-259357_eex-ex99_1.htm:2]** 
- The company updated its **Full Year 2025 guidance** for revenue to **$460-$465 million** and Adjusted EBITDA to **$122.5-$127.5 million**, reflecting the Generis acquisition.  **[1579214_0001193125-25-259357_eex-ex99_1.htm:0]** **[1579214_0001193125-25-259357_eex-ex99_2.htm:4]** **[1579214_0001193125-25-259357_eex-ex99_2.htm:9]** 
- The Board of Directors declared a **dividend of $0.015 per share** for the quarter ending December 31, 2025, and the company repurchased **116,094 shares** for **$0.5 million** in Q3 2025.  **[1579214_0001193125-25-259357_eex-ex99_2.htm:4]** **[1579214_0001193125-25-259357_eex-ex99_2.htm:8]**

Emerald Holding (EEX)